Company / Return on Assets (ROA)
CHINA PHARMA HOLDINGS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-10.3%
FY2025
5-year range
-22.3% / -10.3%
FY2021-FY2025
Trend
+50.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -98.0% in FY2020 to -10.3% in FY2025.
Based on SEC 10-K filings.
-10.3% in FY2025 with a 5-year CAGR of +87.8%.
Improved from -18.7% to -10.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +12.1pp
- 5-Year Change
- +87.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 50.3% year-over-year.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.3% | +50.3% |
| FY2024 | -20.7% | -10.6% |
| FY2023 | -18.7% | +16.3% |
| FY2022 | -22.3% | -76.5% |
| FY2021 | -12.7% | +87.1% |
| FY2020 | -98.0% | -102.8% |
| FY2019 | -48.4% | -13.8% |
| FY2018 | -42.5% | -177.3% |
| FY2017 | -15.3% | +21.9% |
| FY2016 | -19.6% | +51.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026